IV vs. Sublingual Ketamine: Understanding the Differences

Treatment-resistant depression (TRD) affects millions worldwide, leaving many patients frustrated when traditional antidepressants fail to bring relief. In recent years, ketamine therapy has emerged as a breakthrough option, offering rapid, sustained improvement through a completely different biological pathway.

Among available formulations, intravenous (IV) and sublingual ketamine are two of the most effective and commonly prescribed routes. This article explores their pharmacology, benefits, and side-effect profiles to help patients and clinicians make informed decisions about which approach best fits their needs.

Pharmacology Overview

Ketamine is a dissociative anesthetic that works by modulating the glutamate system, specifically by blocking NMDA receptors and activating AMPA receptors, which stimulate neuroplasticity and synaptic repair.
This process helps “reset” brain circuitry involved in mood regulation, often providing relief within hours or days rather than weeks.

IV Ketamine

  • Route: Intravenous infusion

  • Pharmacokinetics: Immediate absorption with peak plasma levels within minutes

  • Metabolism: Metabolized by the liver into norketamine and other active metabolites

  • Onset of Action: 2–5 minutes

  • Duration: As long as infused

  • Bioavailability: 100%

Key Takeaway: IV ketamine delivers full bioavailability and precise dosing, making it the most controlled and rapid-acting option for severe or acute depressive episodes.

Sublingual Ketamine

  • Route: Placed under the tongue and held for absorption through oral mucosa

  • Pharmacokinetics: Gradual onset with peak plasma levels at ~20–40 minutes

  • Metabolism: Hepatic metabolism following mucosal and partial gastrointestinal absorption

  • Onset of Action: 10–20 minutes

  • Duration: 2–4 hours

  • Bioavailability: 25–35%

Key Takeaway: Sublingual ketamine offers a slower, gentler rise in blood levels and a longer-lasting effect, making it ideal for at-home or maintenance therapy under medical supervision.

Achieving Dissociation with Sublingual Dosing:
While the sublingual route produces lower bioavailability compared to IV administration, patients can still experience meaningful dissociation and therapeutic depth when properly dosed. Achieving a similar intensity typically requires approximately 2–3 times the IV-equivalent dose, given the reduced absorption through the mucosal surface. In structured programs like those at Discreet Ketamine, dosing is carefully titrated to each patient’s tolerance and therapeutic goal, ensuring safety while maximizing antidepressant benefit.

Benefit and Effectiveness

IV Ketamine

  • Rapid Relief: Typically reduces depressive symptoms within hours; especially useful in crisis or suicidal ideation. Can be obtained same day.

  • Clinical Oversight: Administered by medical professionals with continuous monitoring of blood pressure and heart rate.

  • Adjustable Dosing: Allows for real-time titration to achieve optimal therapeutic effects.

Sublingual Ketamine

  • Convenience: Taken at home under physician guidance, reducing the need for frequent in-office visits.

  • Sustained Benefit: Effects can last longer than IV sessions, supporting ongoing symptom control.

  • Comfort: Non-invasive and needle-free, ideal for patients seeking a more relaxed therapeutic experience.

  • Affordability: Typically more cost-effective than in-clinic IV infusions.

  • Autonomy: Patients can self-administer under structured medical oversight, with follow-up to assess progress.

Side Effects and Tolerability

Because IV and sublingual ketamine share the same mechanism of action, their side effects overlap—but their intensity and timing may differ.

Common Side Effects (Both Routes)

  • Mild dissociation or dreamlike sensation

  • Nausea or dizziness

  • Short-term elevation in blood pressure or heart rate

  • Fatigue or sedation after the session

IV Ketamine Specifics

  • Dissociation and perceptual changes can be stronger and appear quickly during the infusion.

  • Requires in-clinic monitoring for vital sign stability.

  • Same day treatment, no need to wait for compounding pharmacy.

Sublingual Ketamine Specifics

  • Dissociation is typically more gradual and prolonged.

  • Some patients experience mild oral numbness or a bitter taste.

  • Can be ordered for at home use.

IV vs Sublingual Ketamine

Choosing the Right Option

The choice between IV and sublingual ketamine depends on:

  • The urgency of symptoms

  • Comfort with in-office vs. at-home administration

  • Cost considerations and accessibility

  • Previous treatment response and personal preference

At Discreet Ketamine, we personalize every treatment plan to align with your medical profile, comfort level, and long-term goals. Understanding the differences in pharmacology, benefit/effectiveness, and side effects can help clinicians and patients make informed decisions to find the most suitable treatment approach for their condition. The choice between IV and sublingual treatment depends on various factors, including the patient's clinical status, convenience, and the level of clinician supervision required.


Discreet Ketamine provides ketamine therapy for at-home treatment to Florida residents.


Dr. Ben Soffer

Former chair of Internal Medicine at St. Mary’s Medical Center in West Palm Beach, Florida and associate professor at FAU Medical School. Dr. Ben is the owner of a concierge Internal Medicine practice in Palm Beach County, Florida and Discreet Ketamine, a telemedicine mental health practice servicing the entire state. He resides in Boca Raton, Florida with his wife and four children.

Previous
Previous

ODT/RDT vs. Troche: Maximizing Oral Drug Absorption

Next
Next

Ketamine History: Its Origin and Science